Serum levels of T3 and T4 in hyperthyroidism during the administration of antithyroid drugs
Gómez Vargas, E.; García Vela, A.; Ruelas, G.; López, M.A.; Malacara, J.M.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 30(3): 265-271
1978
ISSN/ISBN: 0034-8376
PMID: 80813
Accession: 038978896
PDF emailed within 1 workday: $29.90
Related References
Suzuki, S.; Ichikawa, K.; Nagai, M.; Mikoshiba, M.; Mori, J.; Kaneko, A.; Sekine, R.; Asanuma, N.; Hara, M.; Nishii, Y.; Yamauchi, K.; Aizawa, T.; Hashizume, K. 1997: Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs Archives of Internal Medicine 157(6): 693-696Suzuki, S.; Ichikawa, K.; Yamauchi, K.; Aizawa, T.; Hashizume, K.; Nagai, M.; Mikoshiba, M.; Mori, J.I.; Kaneko, A.; Sekine, R.; Asanuma, N.; Hara, M.; Nishii, Y. 1997: Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease: A novel side effect of antithyroid drugs Archives of Internal Medicine (1960) 157(6): 693-696
Kuo, S.W.; Huang, W.S.; Wu, S.Y. 1994: Effect of thyroxine administration on serum TSH receptor antibody and thyroglobulin levels in patients with Graves hyperthyroidism during antithyroid drug therapy Clinical Research 42(1): 43A
Kuo, S.W.; Huang, W.S.; Hu, C.A.; Liao, W.K.; Fung, T.C.; Wu, S.Y. 1994: Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy European Journal of Endocrinology 131(2): 125-130
Zuhur, S.S.; Yildiz, I.; Altuntas, Y.; Bayraktaroglu, T.; Erol, S.; Sahin, S.; Kilinc, F.; Akbaba, G.; Topcu, B.; Elbuken, G.; Kadioglu, P. 2020: The effect of gender on response to antithyroid drugs and risk of relapse after discontinuation of the antithyroid drugs in patients with Graves' hyperthyroidism: a multicentre study Endokrynologia Polska 71(3): 207-212
Tsatsoulis, A.; Vlachoyiannopoulos, P.G.; Dalekos, G.M.; Moutsopoulos, H.M. 1993: Serum IL-1-beta increases during treatment of hyperthyroidism with antithyroid drugs Journal of Endocrinology 139(Suppl ): P105
Vander Laan, W.P. 1957: Results of administration of desiccated thyroid to subjects in remission from hyperthyroidism after treatment with antithyroid drugs New England Journal of Medicine 256(11): 511-512
Grzywa, M.; Zuzak, Z. 2006: Antithyroid drugs and lithium carbonate administration relationship to the results of radioiodine treatment of hyperthyroidism Polskie Archiwum Medycyny Wewnetrznej 115(4): 366-370
Tsatsoulis, A.; Vlachoyiannopoulos, P.G.; Dalekos, G.N.; Johnson, E.O.; Moutsopoulos, H.M. 1995: Increased serum interleukin-1 beta during treatment of hyperthyroidism with antithyroid drugs European Journal of Clinical Investigation 25(9): 654-658
Barsal, G.; Taneli, F.; Atay, A.; Hekimsoy, Z.; Erciyas, F. 2004: Serum osteocalcin levels in hyperthyroidism before and after antithyroid therapy Tohoku Journal of Experimental Medicine 203(3): 183-188
Huang, C.S.; Tseng, F.Y.; Chang, T.C.; Chang, C.C.; Chen, F.W.; Torng, J.K. 1983: The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 16(4): 277-282
Roti, E.; Gardini, E.; Minelli, R.; Bianconi, L.; Salvi, M.; Gavaruzzi, G.; Braverman, L.E. 1993: Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism Journal of Clinical Endocrinology and Metabolism 76(4): 928-932
Gardner, D.F.; Rothman, J.; Utiger, R.D. 1979: Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 131i and antithyroid drugs Clinical Endocrinology 11(6): 585-594
Iwaki, H.; Ohba, K.; Okada, E.; Murakoshi, T.; Kashiwabara, Y.; Hayashi, C.; Matsushita, A.; Sasaki, S.; Suda, T.; Oki, Y.; Gemma, R. 2021: Dose-Dependent Influence of Antithyroid Drugs on the Difference in Free Thyroxine Levels between Mothers with Graves' Hyperthyroidism and their Neonates European Thyroid Journal 10(5): 372-381
Glinoer, D.; de Nayer, P.; Bex, M. 2001: Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study European Journal of Endocrinology 144(5): 475-483
Kautbally, S.; Alexopoulou, O.; Daumerie, C.; Jamar, F.ço.; Mourad, M.; Maiter, D. 2012: Greater Efficacy of Total Thyroidectomy versus Radioiodine Therapy on Hyperthyroidism and Thyroid-Stimulating Immunoglobulin Levels in Patients with Graves' Disease Previously Treated with Antithyroid Drugs European Thyroid Journal 1(2): 122-128
Kim, H.; Lee, J.; Ha, J. 2018: A case of antithyroid drug-induced agranulocytosis from a second antithyroid drugs (ATD) administration in a relapsed Graves' disease patient who was tolerant to the first ATD treatment Clinical Case Reports 6(9): 1701-1703
Felicilda-Reynaldo, R.F.D.; Kenneally, M. 2016: Antithyroid Drugs for Hyperthyroidism Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 25(1): 50-54
McGAVACK, T.H. 1952: The use of antithyroid drugs in hyperthyroidism Medical Clinics of North America 36(3): 603-621
McGAVACK, T.H. 1952: The use of antithyroid drugs in hyperthyroidism Medical Clinics of North America 36(3): 603-621